Giovanni Brandi;Francesco de Rosa;Laura Calzà;Stefania Di Girolamo;Manuel Tufoni;Carmen Serena Ricci;Fabio Cirignotta;Paolo Caraceni;Guido Biasco, Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?, «LIVER INTERNATIONAL», 2013, 33, pp. 488 - 493 [Scientific article]
Brandi G; Venturi M; Dika E; Maibach H; Patrizi A; Biasco G., Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?, «CUTANEOUS AND OCULAR TOXICOLOGY», 2013, 32, pp. 336 - 338 [Scientific article]
Tovoli A; Napoli L; Mastroroberto M; Renzulli M; Tufoni M; Ricci CS; Golfieri R; Brandi G., Extrahepatic Feeding of HCC Limits the Use of TACE? Evidences from Literature and Clinical Experience, «JOURNAL OF CANCER THERAPY», 2013, 4, Article number: 28486 , pp. 413 - 419 [Scientific article]
Brandi G.; De Rosa F. ; Liguori G. ; Agostini V.; Di Girolamo S. ; Gaboriau-Routhiau V. ; Raibaud P. ; Biasco G., Intestinal microbiota around colorectal cancer genesis, in: The Research and Biology of Cancer II, iConcept Press Ltd, 2013 [Chapter or essay]
G. Brandi; F. de Rosa; V. Agostini; S. Di Girolamo; P. Andreone; L. Bolondi; C. Serra; C. Sama; R. Golfieri; A. Gramenzi; A. Cucchetti; A. D. Pinna; F. Trevisani; G. Biasco; and the Italian Liver Cancer (ITA.LI.CA) group., Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study., «THE ONCOLOGIST», 2013, 18, pp. 1256 - 1257 [Scientific article]
Dora Colussi;Giovanni Brandi;Franco Bazzoli;Luigi Ricciardiello, Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2013, 14, pp. 16365 - 16385 [Scientific article]
L. Fornaro; S. Cereda; F. Bergamo; F. Leone; M. Russano; N. Silvestris; J. Corbelli; V. Rotella; C. Vivaldi; G. Brandi, Multivariate prognostic factor analysis in patients (pts) with advanced biliary tract cancer (aBTC) treated with second-line chemotherapy (CT), in: European Cancer Congress 2013 (ECCO-ESMO-ESTRO), 2013(atti di: European Cancer Congress 2013 (ECCO-ESMO-ESTRO), Amsterdam, Netherlands, 27 Settemre - 1 Ottobre 2013) [Poster]
M. Paragona; D. Campana; E. Nobili; Tomassetti P; G. Biasco; G. Brandi, PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS, in: 10th Annual Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, 2013, pp. 137 - 137 (atti di: 10th Annual Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, 6-8 March 2013) [Abstract]
Brandi G; Tavolari S; Vasuri F, Farioli A; Deserti M; Frega G; Corbelli J; Barbera MA; Pantaleo MA; Di Girolamo S; Biasco G., Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) predicts better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients., in: ASCO ANNUAL MEET 2013, «JOURNAL OF CLINICAL ONCOLOGY», 2013, 31 (suppl)(atti di: ASCO ANNUAL MEET 2013, Chicago, june 4 2013) [Abstract]
Giovanni, Brandi; Simona, Tavolari; Francesco, Vasuri; Andrea, Farioli; Marzia, Deserti; Giorgio, Frega; Jodi, Corbelli; Aurelia, Barbera Maria; Pantaleo Maria, A; Stefania, Di Girolamo; Guido, Biasco, Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) to predict better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients., «JOURNAL OF CLINICAL ONCOLOGY», 2013, 31, pp. 1503 - 1503 [Abstract]
Garajová I; Nepoti G; Paragona M; Brandi G; Biasco G, Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation., «EUROPEAN JOURNAL OF CANCER CARE», 2013, 22, pp. 125 - 132 [Scientific article]
Fornaro L; Cereda S; Bergamo F; Lutrino SE; Leone F; Santini D; Vaccaro V; Silvestris N; Corbelli J; Vasile E; Milella M; Aprile G; Vivaldi C; Barbera A; Filippi R; Caparello C; Mioranza E; Ferrari L; Baldini E; Reni M; Brandi G, Prognostic model for patients with advanced biliary tract cancer (ABTC) receiving second-line chemotherapy (CT), in: I supplementi di Tumori, «TUMORI», 2013, pp. S170 - S170 (atti di: XV congresso nazionale AIOM 2013, Milano, 11-13 Ottobre 2013) [Poster]
E. Vasile; S. Di Girolamo; S. Cereda; S. Lonardi; F. Leone; M. Russano; N. Silvestris; C. Vivaldi; L. Fornaro; G. Brandi, Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey, in: European Cancer Congress 2013, 2013(atti di: European Cancer Congress 2013, Amsterdam, Netherlands, 27 Settembre - 1 Ottobre 2013) [Poster]
Granata M.; Brandi G.; Borsari A.; Gasbarri R.; Di Gioia D., Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain, «INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION», 2013, 64, pp. 162 - 168 [Scientific article]
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R., Unresectable perihilar cholangiocarcinoma: multimodal
palliative treatment, «ANTICANCER RESEARCH», 2013, 33, pp. 2747 - 2753 [Scientific article]
